Structural optimization and structure-functional selectivity relationship studies of G protein-biased EP2 receptor agonists

Bioorg Med Chem Lett. 2016 May 15;26(10):2446-2449. doi: 10.1016/j.bmcl.2016.03.110. Epub 2016 Mar 31.

Abstract

The modification of the novel G protein-biased EP2 agonist 1 has been investigated to improve its G protein activity and develop a better understanding of its structure-functional selectivity relationship (SFSR). The optimization of the substituents on the phenyl ring of 1, followed by the inversion of the hydroxyl group on the cyclopentane moiety led to compound 9, which showed a 100-fold increase in its G protein activity compared with 1 without any increase in β-arrestin recruitment. Furthermore, SFSR studies revealed that the combination of meta and para substituents on the phenyl moiety was crucial to the functional selectivity.

Keywords: Agonist; Biased ligand; EP2; Prostaglandin; Structure–functional selectivity relationship.

MeSH terms

  • Drug Screening Assays, Antitumor / methods
  • GTP-Binding Proteins / chemistry
  • Humans
  • Oligopeptides / chemistry
  • Oligopeptides / pharmacology
  • Receptors, Prostaglandin E, EP2 Subtype / agonists*
  • Structure-Activity Relationship*

Substances

  • Oligopeptides
  • PTGER2 protein, human
  • Receptors, Prostaglandin E, EP2 Subtype
  • GTP-Binding Proteins
  • Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OH